Overview


According to FutureWise analysis, the market for aortic valve replacement devices is expected to register a CAGR of 11.3% from 2023 to 2031. The rising prevalence of aortic stenosis and other valvular heart diseases drives the market growth. At the same time, patients are showing a strong preference for cutting-edge, minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR). Innovations in next-generation valves offer enhanced durability and fewer complications, making these options even more appealing. With an aging global population seeking practical solutions, the adoption of these advanced treatments is gaining momentum, transforming patient care.

Aortic Valve Replacement (AVR) devices are medical devices used to replace a diseased or damaged aortic valve in the heart. The aortic valve is one of four valves in the heart, responsible for regulating blood flow. When the aortic valve is diseased or not functioning correctly, it can lead to symptoms such as fatigue, chest pain, and shortness of breath. Aortic valve disease can take two primary forms: Aortic Stenosis, a disease where the aortic valve narrows, decreasing blood flow from the heart into the aorta. This puts extra pressure on the heart and can lead to symptoms like chest pain, fainting, and heart failure. Aortic Regurgitation occurs when the aortic valve fails to close properly, allowing blood to flow back into the heart. This can also lead to symptoms like fatigue, shortness of breath, and heart failure.

There are several types of aortic valve replacement devices. Transcatheter Aortic Valve Replacement (TAVR): This is a less invasive procedure in which a replacement valve is inserted through a catheter, typically via an artery in the leg, and directed to the heart. This avoids the need for open-heart surgery. TAVR is commonly used for patients who are at high risk or not suitable candidates for traditional surgery. Also a sutureless valve, also known as a rapid deployment valve, is an artificial heart valve used in aortic valve replacement procedures. It was created to simplify and expedite the surgical process. Traditional aortic valve replacement involves suturing (stitching) the replacement valve into place. In contrast, a sutureless valve is designed to be implanted without requiring multiple sutures. Instead, it typically uses anchoring mechanisms or other specialized components to secure the valve in position.

FutureWise Market Research has published a report that provides an insightful analysis aortic valve replacement devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts aortic valve replacement devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Boston Scientific Corporation
  • Cryolife, Inc.
  • Edward Lifesciences Corporation
  • LivaNova PLC. (Sorin Group)
  • Medtronic
  • St. Jude Medical (Abbott)
  • Symetis SA

(Note: The list of the major players will be updated with the latest market scenario and trends)


Recent developments by key players in the Aortic Valve Replacement Devices Market: 

Medtronic

  • Medtronic launched the Avalus Ultra in January 2024, introducing a next-generation surgical cardiac tissue valve designed for ease of use in surgery, long-term durability, and valve-in-valve compatibility. It features enhanced visibility due to a radiopaque coil embedded in the PEEK base frame.
  • The Evolut TAVR Five-Year Outcomes (March 2025) show that late-breaking data from the Evolut Low Risk Trial demonstrated durable valve performance and superior long-term clinical outcomes compared to traditional surgical approaches.

Edward Lifesciences Corporation

  • In Q2 2025, Edwards reported strong results with TAVR sales increasing by approximately 9%, which reinforces its leadership position. The exit of rival Boston Scientific from the TAVR market in Europe has further strengthened Edwards’ dominance.
  • The company anticipates receiving FDA approval for TAVR (Transcatheter Aortic Valve Replacement) in patients with asymptomatic severe aortic stenosis by mid-2025. This approval could serve as a significant growth driver by allowing for earlier intervention. Furthermore, the company is expanding its focus to include therapies for mitral and tricuspid valves, with projected sales potentially reaching up to $2 billion by 2030.

By Surgery

  • Open surgery
  • Minimally invasive surgery

By Product

  • Transcatheter aortic valve
  • Sutureless valve
  • Others

By End User

  • Hospitals
  • Ambulatory surgery centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Aortic Valve Replacement Devices Market By Surgery, By Product, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aortic Valve Replacement Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aortic Valve Replacement Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aortic Valve Replacement Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aortic Valve Replacement Devices Market, By Surgery Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Open surgery
        2. Minimally invasive surgery

  • 8.   Aortic Valve Replacement Devices Market, By Product Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Transcatheter aortic valve
        2. Sutureless valve
        3. Others

  • 9.   Aortic Valve Replacement Devices Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Hospitals
        2. Ambulatory surgery centers
        3. Others

  • 10.   North America Aortic Valve Replacement Devices Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 11.   Latin America Aortic Valve Replacement Devices Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 12.   Europe Aortic Valve Replacement Devices Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 13.   Asia Pacific Aortic Valve Replacement Devices Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 14.   Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Boston Scientific Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cryolife, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Edward Lifesciences Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. LivaNova PLC. (Sorin Group)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Medtronic
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. St. Jude Medical (Abbott)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Symetis SA
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Aortic Valve Market

Read More

Transcatheter Aortic Valve Replacement Market

Read More
Partner

Our Clients